We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Portable Monitoring System Tracks Real-Time Brain Activity

By LabMedica International staff writers
Posted on 07 Feb 2016
Print article
Image: The Cognionics wearable 72-channel EEG headset (Photo courtesy of Cognionics).
Image: The Cognionics wearable 72-channel EEG headset (Photo courtesy of Cognionics).
An innovative wearable brain activity monitoring system with dry electroencephalogram (EEG) sensors provides a better solution for real-world applications.

Developed by researchers at the University of California, San Diego (UCSD, USA), the HD-72 headset features a wearable 72-channel (64 EEG + 8 ExG) form factor, compact electronics with active shielding, and a wireless triggering system. Active dry-contact electrodes leverage a pressure-induced flexing mechanism to contact the scalp through hair. A sophisticated software suite wirelessly streams data for online analysis, including adaptive artifact rejection, cortical source localization, multivariate effective connectivity inference, data visualization, and cognitive state classification.

The octopus-like headset has 18 tentacles, in which each arm is elastic, so that it can fit different head shapes. The sensors at the end of each arm are designed to make optimal contact with the scalp while adding as little noise in the signal as possible. The sensors are are made of a mix of silver and carbon deposited on a flexible substrate with a silver/silver-chloride coating. This allows them to remain flexible and durable while still conducting high-quality signals. The data captured is first separated from high amplitude artifacts generated when subjects move, speak, or even blink.

This is achieved by an algorithm that separates the EEG data into different components statistically unrelated to one another. It then compares these elements with clean data obtained, for instance, when a subject is at rest; abnormal data is labeled as noise and discarded. The data collected is also tracked to see how signals from different areas of the brain interact with one another, creating an ever-changing network map of brain activity. Machine learning then connects specific network patterns in brain activity to cognition and behavior. The study describing the system was published in the November 2015 issue of IEEE Transactions on Biomedical Engineering.

“This is going to take neuroimaging to the next level by deploying on a much larger scale. You will be able to work in subjects’ homes; you can put this on someone driving,” said study coauthor Mike Yu Chi, MSc and CTO of Cognionics (San Diego, CA, USA), which is developing the system commercially.

Related Links:

University of California, San Diego
Cognionics


New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Hemoglobin Testing System
VARIANTnbs

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.